FCRLB/FCRY Antibody (465905) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # FAB4868W

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Monoclonal Rat IgG2A Clone # 465905
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse FCRLB/FCRY
Ala18-Ser427
Accession # Q5DRQ8
Ala18-Ser427
Accession # Q5DRQ8
Specificity
Detects mouse FCRLB/FCRY in direct ELISAs and Western blots. In Western blots, 75% cross-reactivity with recombinant human FCRLB is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for FCRLB/FCRY Antibody (465905) [DyLight 650]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FCRLB/FCRY
Long Name
Fc Receptor-like B
Alternate Names
FcRL2, FCRLM2, FCRLY, FCRY, FREB-2
Gene Symbol
FCRLB
Additional FCRLB/FCRY Products
Product Documents for FCRLB/FCRY Antibody (465905) [DyLight 650]
Product Specific Notices for FCRLB/FCRY Antibody (465905) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...